Narendra Wajapeyee

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 16

Top Topics

Epidermal Growth Factor Receptor

Advanced Non Small Cell Lung Cancer

Long Noncoding Rna

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Mehmet Akce, Bassel F El-Rayes, Narendra Wajapeyee
Combinatorial targeting of immune checkpoints and epigenetic regulators for hepatocellular carcinoma therapy. Oncogene (2023)
Suresh Bugide, Yvonne J K Edwards, Romi Gupta, Michael R Green, Narendra Wajapeyee
CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer. Proceedings of the National Academy of Sciences of the United States of America 120 (4) (2023)
Suresh Bugide, Yvonne J K Edwards, Romi Gupta, Michael R Green, Narendra Wajapeyee
CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer. Proceedings of the National Academy of Sciences of the United States of America 120 (4) (2023)
Suresh Bugide, Yvonne J K Edwards, Romi Gupta, Michael R Green, Narendra Wajapeyee
CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer. Proceedings of the National Academy of Sciences of the United States of America 120 (4) (2023)
Suresh Bugide, Yvonne J K Edwards, Romi Gupta, Michael R Green, Narendra Wajapeyee
CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer. Proceedings of the National Academy of Sciences of the United States of America 120 (4) (2023)
Parmanand Malvi, Dhana Sekhar Reddy, Raj Kumar, Suresh Chava, Sneha Burela, Keshab Parajuli, Xuchen Zhang, Narendra Wajapeyee
LIMK2 promotes melanoma tumor growth and metastasis through G3BP1-ESM1 pathway-mediated apoptosis inhibition. Oncogene (2023)
Suresh Bugide, Yvonne J K Edwards, Romi Gupta, Michael R Green, Narendra Wajapeyee
CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer. Proceedings of the National Academy of Sciences of the United States of America 120 (4) (2023)
Suresh Bugide, Yvonne J K Edwards, Romi Gupta, Michael R Green, Narendra Wajapeyee
CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer. Proceedings of the National Academy of Sciences of the United States of America 120 (4) (2023)
Lili Pan, Chao Hong, Lai N Chan, Gang Xiao, Parmanand Malvi, Mark E Robinson, Huimin Geng, Srinivasa T Reddy, Jaewoong Lee, Vishal Khairnar, Kadriye Nehir Cosgun, Liang Xu, Kohei Kume, Teresa Sadras, Shaoyuan Wang, Narendra Wajapeyee, Markus Müschen
PON2 subverts metabolic gatekeeper functions in B cells to promote leukemogenesis. Proceedings of the National Academy of Sciences of the United States of America 118 (7) (2021)
Suresh Bugide, Romi Gupta, Michael R Green, Narendra Wajapeyee
EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner. Proceedings of the National Academy of Sciences of the United States of America 118 (30) (2021)
Vipin Rawat, Parmanand Malvi, Deborah Della Manna, Eddy Shih-Hsin Yang, Suresh Bugide, Xuchen Zhang, Romi Gupta, Narendra Wajapeyee
PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1. Oncogene 40 (13) (2021)
Romi Gupta, Radoslav Janostiak, Narendra Wajapeyee
Transcriptional regulators and alterations that drive melanoma initiation and progression. Oncogene 39 (48) (2020)
Parmanand Malvi, Radoslav Janostiak, Suresh Chava, Padmini Manrai, Esther Yoon, Kamaljeet Singh, Malini Harigopal, Romi Gupta, Narendra Wajapeyee
LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1. Oncogenesis 9 (8) (2020)
Parmanand Malvi, Radoslav Janostiak, Arvindhan Nagarajan, Guoping Cai, Narendra Wajapeyee
Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression. PLoS genetics 15 (10) (2019)
Malik Bisserier, Narendra Wajapeyee
Mechanisms of resistance to EZH2 inhibitors in diffuse large B-cell lymphomas. Blood 131 (19) (2018)
Romi Gupta, Matteo Forloni, Malik Bisserier, Shaillay Kumar Dogra, Qiaohong Yang, Narendra Wajapeyee
Interferon alpha-inducible protein 6 regulates NRASQ61K-induced melanomagenesis and growth. eLife 5 (2016)